Social Media Influencers Fueling Parallel Market for Unapproved Weight-Loss Medication

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Some experts said the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has taken down problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Information and Pricing

Within these communities, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious medical dangers”.